Prostate Cancer Outcomes: International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRonMan)

The Prostate Cancer Outcomes (PCO) International Registry is designed to create an international, population-based registry of 5,000 men with advanced prostate cancer and to describe variations in patient management, experiences, and outcomes in this population. The PCO International Registry will recruit 5,000 patients with advanced prostate cancer internationally, including 500 men with newly diagnosed metastatic hormone sensitive prostate cancer and 4,500 men with M0 and M1 castrate-resistant prostate cancer. Standardised patient-reported outcomes will be collected every 6 months for years 1 and 2, and every 3 months thereafter. Collection of baseline demographics/prior therapies and blood collection will follow informed consent, with follow up data collected for overall survival, skeletal events, hospitalisations, incidence of cardiovascular disease, cancer and acute and chronic diseases, bone scan and imaging.

This information will:

-       Inform best treatment practices for patients with advanced disease

-       Describe the clinical and molecular subtypes of advanced disease

-       Define unmet needs for further study particularly emphasising patient experiences


Pretoria Bilinski Greenslopes Private Hospital
Geoffrey Coughlin Royal Brisbane & Women's Hospital, Wesley Hospital and Wesley Urology Clinic
Katharine Cuff PAH
James MacKean Genesis CancerCare QLD
Colleen Nelson APCRC-Q, IHBI, QUT, PAH, TRI
David Pryor APCRC-Q, PAH
Christopher Tracey

Gold Coast Urology, Gold Coast University Hospital, Pindara Private Hospital

Euan Walpole PAH
Roger Watson Mater Hospital and Urology South Brisbane
Simon Wood Greenslopes Urology Clinic


2016 - 2020


Movember Foundation